2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine has been researched along with Primary Peritonitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feterowski, C; Holzmann, B; Kaiser-Moore, S; Mühlradt, PF; Novotny, A; Rossmann-Bloeck, T; Rump, M; Weighardt, H | 1 |
1 other study(ies) available for 2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine and Primary Peritonitis
Article | Year |
---|---|
Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation.
Topics: Animals; Base Sequence; Chemokines; Cysteine; Cytokines; DNA, Complementary; Female; Interleukin-1 Receptor-Associated Kinases; Interleukin-1 Receptor-Like 1 Protein; Lipopeptides; Lipoproteins; Macrophage Activation; Membrane Proteins; Mice; Mice, Inbred C57BL; Neutrophils; Oligopeptides; Peritonitis; Protein Kinases; Receptors, Immunologic; Receptors, Interleukin; RNA, Messenger; Signal Transduction; Toll-Like Receptor 2; Up-Regulation | 2005 |